PQS: PharmOutcomes support

PQS: PharmOutcomes support

October 1, 2019

Community pharmacy contractors can access support on PharmOutcomes for the Pharmacy Quality Scheme (PQS) 2019/20, and further support will be available soon. This support is available to all contractors free of charge as PSNC has agreed to use their PharmOutcomes licence to provide access to this support.

Currently, support is available to assist contractors with meeting the asthma quality criterion. There are two services available; one for patients for whom more than six short-acting bronchodilator inhalers were dispensed without any corticosteroid inhaler within a six month period and one for children who have not been prescribed a spacer device and/or do not have a personalised asthma action plan.

This PharmOutcomes tool allows contractors to record patient details who have consented to be referred to their GP practice. When this data is saved on PharmOutcomes, a referral will automatically be sent to the patient’s GP practice (if an NHSmail email address is held for that GP practice on PharmOutcomes).

Once a contractor has logged into PharmOutcomes, the tool can be accessed by clicking on ‘Services’; and then the two services are listed under the title ‘Pharmacy Quality Scheme – Quality criteria’.

The following audits/frameworks will also be available shortly; we will alert contractors through our normal communication channels when these become available:

  • PQS assessment framework;
  • Lithium audit*;
  • Methotrexate audit*;
  • Amiodarone audit*;
  • Phenobarbital audit*;
  • Valproate safety audit;
  • NSAID audit; and
  • Dementia-friendly environment checklist.

If a contractor has not used PharmOutcomes before, log in details can be obtained by sending a message to the PharmOutcomes helpdesk. Contractors will need to provide details of the pharmacy, contact information and an email address to issue the login details to. 

 *Contractors are only required to complete one of these audits in the following order of preference: lithium; methotrexate; amiodarone; or phenobarbital. Please see pages 29-42 of the NHS England PQS guidance for further information.

Posted in: , ,

More Latest News >